Novo Nordisk Rare Disease is a speciality care unit focused on generating scientific and technological breakthroughs for people with rare diseases. We have a 40-year legacy and expertise in rare blood and endocrine disorders, which make us ideally placed to drive innovations to lessen the burden and truly achieve life-changing benefits for people living with a rare disease – a population where the unmet need remains high and collectively affects around 350 million people across the globe. Learn more about how we drive change in rare disease
here.